Arrow Alexander K. 4

4 · Protagenic Therapeutics, Inc.\new · Filed Oct 13, 2023

Insider Transaction Report

Form 4
Period: 2023-10-12
Arrow Alexander K.
Chief Financial Officer
Transactions
  • Purchase

    PTIX Common Stock

    2023-10-12$0.81/sh+8,000$6,48045,815 total

Documents

1 file
  • 4
    ownership.xmlPrimary